Development of Patients Reported Outcome of Ulcerative Colitis:prospective multicenter cohort study

Development of Patients Reported Outcome of Ulcerative Colitis:prospective multicenter cohort study - PROUC study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000022246

Enrollment

100

Registered

2016-05-09

Start date

2016-04-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative Colitis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: moderate and severe UC

Exclusion criteria

Exclusion criteria: Past history of anti TNF alpha treatment

Design outcomes

Primary

Measure	Time frame
Remission after 14 weeks from the start of anti TNF alpha	—

Secondary

Measure	Time frame
Lichtiger score <=4(6 week), Lichtiger score<=2(6,14 week), clinicak effecacy rate(6,14 week),DAI score(14 week), partial DAI score(6,14 week), negative CRP rate(6,14 week),CRP(6,14 week), EQ-5D-3L(1,2,4,8,12 week) QALY, endoscopic remission(12 week)	—

Countries

Japan

Contacts

Public ContactMasayasu Horibe

Keio University School of Medicine Division of Gastroenterology and Hepatology Department of Internal Medicine

masayasu-horibe@umin.ac.jp+81-3-5363-3790

Outcome results